首页> 外国专利> IDIOTYPICALLY MODULATED PHARMACOEFFECTORS FOR SELECTIVE CELL INFLUENCE

IDIOTYPICALLY MODULATED PHARMACOEFFECTORS FOR SELECTIVE CELL INFLUENCE

机译:具有典型细胞调制作用的选择性细胞影响药物

摘要

1. A method comprising: introducing into a population of cells instructions for manufacturing a plurality of idiotypically modulated pharmacoeffectors (IMPs), each of a plurality of manufactured IMPs comprises: a detection domain of one or more nucleotide sequences that have affinity for conjugated sequences, and an activation domain connected to it a detection domain, wherein the detection domain of each IMP subgroup of a plurality of manufactured IMPs is configured to link one or more sequences; where the activation domain of each IMP subgroup of a plurality of manufactured IMPs is configured to activate and cause a downward cascading effect in the cell population. 2. The method of claim 1, wherein the instructions are encoded on a plasmid. The method of claim 1, wherein the cell population includes blood flow. The method of claim 1, wherein the cell population comprises tissue culture. The method of claim 1, wherein the activation domain comprises proapoptotic caspase. A method comprising: introducing a plurality of engineered idiotypically modulated pharmacoeffectors (IMPs) into a cell population, each IMP comprises: a detection domain of one or more nucleotide sequences that have affinity for conjugated sequences, and an activation domain linked to a detection domain; linking the detection domain of each IMP subgroups of multiple IMPs with one or more sequences; and activation of the activation domain of each IMP subgroup of the set of IMPs, activation causing a downward cascading effect in each cell of at least a subgroup of the cell population. 7. The method according to
机译:1.一种方法,包括:向细胞群中引入用于制造多个独特型调节的药物效应子(IMP)的指令,多个制造的IMP中的每一个包括:一个或多个对缀合序列具有亲和力的核苷酸序列的检测域,以及与之相连的激活域的检测域,其中多个制造的IMP的每个IMP子组的检测域被配置为链接一个或多个序列;其中多个制造的IMP的每个IMP亚组的激活域被配置为激活并引起细胞群体的向下级联效应。 2.根据权利要求1所述的方法,其中,所述指令在质粒上编码。 2.根据权利要求1所述的方法,其中,所述细胞群包括血流。 3.根据权利要求1所述的方法,其中,所述细胞群体包括组织培养物。 2.根据权利要求1所述的方法,其中,所述激活结构域包括促凋亡的胱天蛋白酶。一种方法,包括:将多个工程改造的独特型药物效应子(IMP)引入细胞群,每个IMP包括:一个或多个对缀合序列具有亲和力的核苷酸序列的检测域,和与该检测域连接的活化域;将多个IMP的每个IMP子组的检测域与一个或多个序列链接;以及该组IMP的每个IMP子组的激活域的激活,激活在细胞群的至少一个子组的每个细胞中引起向下的级联效应。 7.根据的方法

著录项

  • 公开/公告号RU2012157791A

    专利类型

  • 公开/公告日2014-07-20

    原文格式PDF

  • 申请/专利权人 ОРМЕ ДЖЕЙКОБ (US);

    申请/专利号RU20120157791

  • 发明设计人 ОРМЕ ДЖЕЙКОБ (US);

    申请日2011-05-27

  • 分类号C12N15;

  • 国家 RU

  • 入库时间 2022-08-21 15:39:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号